Live feed
Filing
SC 13G/A
SC 13G/A0001306550-23-005186·4D Molecular Therapeutics, Inc.
Schedule 13G ownership disclosure
4D Molecular Therapeutics Inc
Security class unavailable · CUSIP: 35104E100
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,508,632
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001306550-23-005186
- Form type
- SC 13G/A
- Filer
- 4D Molecular Therapeutics, Inc.
- CIK
- CIK 1650648
- Filed
- Jan 31, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership